Clotrimazole Market Overview:
Clotrimazole is a pharmaceutical drug used in treating dermatological and gynecological fungal infections. Clotrimazole is a derivative of imidazole. Its chemical name is 1-[(2-chlorophenyl) (diphenyl) methyl]-1H-imidazole). With a total capacity of 160 Metric Tons, China is the largest supplier of clotrimazole in the world. The major manufacturing bases of clotrimazole are Europe and India but with a relatively low capacity compared to China.
Request SampleClotrimazole Market Outlook:
Clotrimazole is an antifungal medication used to treat vaginal yeast infections, oral thrush, diaper rash, pityriasis versicolor and ringworms including athlete’s foot and jock itch. The usage of clotrimazole is not going to decrease but increase during the forecast period as the dermatological and gynecological infections are prevalent across the globe.
Clotrimazole Market report comprises of pricing analysis for different strengths of clotrimazole used in drugs. The price of 500 gm clotrimazole used in drugs is the highest among the others and is expected to reach $45 per pill or unit by 2022.
Clotrimazole Market Growth Drivers: As the population in the world is increasing significantly, there are many new dermatological infections including gynecological infections are spreading rapidly around the world in recent years. So, there are many chances of innovating new drugs in the clotrimazole category. This, in turn, boosts the usage of clotrimazole for the infections by driving the global Clotrimazole Market.
Clotrimazole Market Challenges: The main restraints in the global Clotrimazole Market are the side effects of using Clotrimazole. The most common side effects of clotrimazole are redness, blistering, peeling, swelling, itching and burning at the site of application. It will also cause stomach pain, nausea, vomiting, fever, vaginal discharge etc.
Clotrimazole Market Research Scope:
The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Clotrimazole market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of Clotrimazole market and their specific applications in different types of vehicles.
Clotrimazole Market Trends:
According to the Americal Association for Cancer Research, treatment combining the clotrimazole and a short-term romidepsin will lead to a decrease in the mitochondrial hexokinase 2 and apoptosis in the cancer cells. This research is paving a path for the usage of clotrimazole also in the cancer treatment.
In a new research done by the Federal University of São Paulo, São Paulo, Brazil, Clotrimazole was proven highly effective against feline Sporothrix brasiliensis isolates when compared to the Itraconazole. As clotrimazole has a strong activity against feline S. brasiliensis isolates, this suggests that clotrimazole is potentially a new replacement drug for the treatment of feline sporotrichosis.
In another research by the Silpakorn University, Thailand, new micelles have been developed using clotrimazole loaded N-naphthyl-N, O-succinyl chitosan (NSCS) which is used as an alternative for oral candidiasis treatment.
January 3, 2017: Bayer Animal Health had acquired the Cydectin in the US from Boehringer Ingelheim Vetmedica Inc. This acquisition intends to strengthen the antiparasitics portfolio in the US along with the endectocides.
Clotrimazole is a pharmaceutical drug used in treating dermatological and gynecological fungal infections. Clotrimazole is a derivative of imidazole. Its chemical name is 1-[(2-chlorophenyl) (diphenyl) methyl]-1H-imidazole). With a total capacity of 160 Metric Tons, China is the largest supplier of clotrimazole in the world. The major manufacturing bases of clotrimazole are Europe and India but with a relatively low capacity compared to China.
Request SampleClotrimazole Market Outlook:
Clotrimazole is an antifungal medication used to treat vaginal yeast infections, oral thrush, diaper rash, pityriasis versicolor and ringworms including athlete’s foot and jock itch. The usage of clotrimazole is not going to decrease but increase during the forecast period as the dermatological and gynecological infections are prevalent across the globe.
Clotrimazole Market report comprises of pricing analysis for different strengths of clotrimazole used in drugs. The price of 500 gm clotrimazole used in drugs is the highest among the others and is expected to reach $45 per pill or unit by 2022.
Clotrimazole Market Growth Drivers: As the population in the world is increasing significantly, there are many new dermatological infections including gynecological infections are spreading rapidly around the world in recent years. So, there are many chances of innovating new drugs in the clotrimazole category. This, in turn, boosts the usage of clotrimazole for the infections by driving the global Clotrimazole Market.
Clotrimazole Market Challenges: The main restraints in the global Clotrimazole Market are the side effects of using Clotrimazole. The most common side effects of clotrimazole are redness, blistering, peeling, swelling, itching and burning at the site of application. It will also cause stomach pain, nausea, vomiting, fever, vaginal discharge etc.
Clotrimazole Market Research Scope:
The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Clotrimazole market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of Clotrimazole market and their specific applications in different types of vehicles.
Inquiry Before Buying
Clotrimazole Market Report: Industry Coverage
Types of Clotrimazole: Powder, cream, solution (Lotion), lozenges and tablets.
Applications of Clotrimazole: It is used to treat dermatological and gynecological infections like vaginal yeast infections, oral thrush, diaper rash, pityriasis versicolor and ringworms including athlete’s foot and jock itch.
The Clotrimazole market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:
North America: The U.S., Canada, Mexico
South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
The Middle East and Africa: Israel, South Africa, Saudi Arabia
Clotrimazole Market Key Players Perspective:
Some of the other key players mentioned in this report are Bayer, Erregierre, Amoli Organics, Sigma-Aldrich, CordenPharma, Ciron Group, Halcyon Labs, INFA Group, Manus Aktteva, and Jiangsu Yunyang among others.
Clotrimazole Market Report: Industry Coverage
Types of Clotrimazole: Powder, cream, solution (Lotion), lozenges and tablets.
Applications of Clotrimazole: It is used to treat dermatological and gynecological infections like vaginal yeast infections, oral thrush, diaper rash, pityriasis versicolor and ringworms including athlete’s foot and jock itch.
The Clotrimazole market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:
North America: The U.S., Canada, Mexico
South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
The Middle East and Africa: Israel, South Africa, Saudi Arabia
Clotrimazole Market Key Players Perspective:
Some of the other key players mentioned in this report are Bayer, Erregierre, Amoli Organics, Sigma-Aldrich, CordenPharma, Ciron Group, Halcyon Labs, INFA Group, Manus Aktteva, and Jiangsu Yunyang among others.
Clotrimazole Market Trends:
According to the Americal Association for Cancer Research, treatment combining the clotrimazole and a short-term romidepsin will lead to a decrease in the mitochondrial hexokinase 2 and apoptosis in the cancer cells. This research is paving a path for the usage of clotrimazole also in the cancer treatment.
In a new research done by the Federal University of São Paulo, São Paulo, Brazil, Clotrimazole was proven highly effective against feline Sporothrix brasiliensis isolates when compared to the Itraconazole. As clotrimazole has a strong activity against feline S. brasiliensis isolates, this suggests that clotrimazole is potentially a new replacement drug for the treatment of feline sporotrichosis.
In another research by the Silpakorn University, Thailand, new micelles have been developed using clotrimazole loaded N-naphthyl-N, O-succinyl chitosan (NSCS) which is used as an alternative for oral candidiasis treatment.
January 3, 2017: Bayer Animal Health had acquired the Cydectin in the US from Boehringer Ingelheim Vetmedica Inc. This acquisition intends to strengthen the antiparasitics portfolio in the US along with the endectocides.
- We also publish more than 100 reports every month in "Chemicals and Materials", Go through the Domain if there are any other areas for which you would like to get a market research study.
Comments
Post a Comment